Alibaba Health Information Technology Limited (ALBBY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Alibaba Health Information Technology Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Alibaba Health Information Technology Limited (ALBBY) has returned -23.52% so far this year and -15.72% over the past 12 months.

Based on dividend-adjusted daily data since May 7, 2020, ALBBY's average daily return is -0.01%, while the average monthly return is -0.31%.

Historically, 41% of months were positive and 59% were negative. The best month was Nov 2022 with a return of +93.0%, while the worst month was Mar 2026 at -34.6%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ALBBY closed higher 17% of trading days. The best single day was Dec 8, 2022 with a return of +32.0%, while the worst single day was Mar 26, 2026 at -35.2%.

Alibaba Health Information Technology Limited has an annualized alpha of -8.58%, beta of 0.50, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since May 21, 2020.

• This stock participated in 178.10% of S&P 500 Index downside but only 29.26% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.50 may look defensive, but with R² of 0.01 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ALBBY ranks 33 for risk / return — below 33% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Alibaba Health Information Technology Limited (ALBBY) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Alibaba Health Information Technology Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alibaba Health Information Technology Limited was 91.29%, occurring on Apr 15, 2024. The portfolio has not yet recovered.

The current Alibaba Health Information Technology Limited drawdown is 87.28%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Alibaba Health Information Technology Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Alibaba Health Information Technology Limited is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.